The Korea Times
amn_close.png
amn_bl.png
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
amn_bl.png
Business
  • Tech
  • Bio
  • Companies
amn_bl.png
Finance
  • Companies
  • Economy
  • Markets
  • Cryptocurrency
amn_bl.png
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to President
  • Letter to the Editor
amn_bl.png
Lifestyle
  • Travel & Food
  • Trends
  • People & Events
  • Books
  • Around Town
  • Fortune Telling
amn_bl.png
Entertainment & Arts
  • K-pop
  • Films
  • Shows & Dramas
  • Music
  • Theater & Others
amn_bl.png
Sports
amn_bl.png
World
  • SCMP
  • Asia
amn_bl.png
Video
  • Korean Storytellers
  • POPKORN
  • Culture
  • People
  • News
amn_bl.png
Photos
  • Photo News
  • Darkroom
amn_NK.png amn_DR.png amn_LK.png amn_LE.png
  • bt_fb_on_2022.svgbt_fb_over_2022.svg
  • bt_twitter_on_2022.svgbt_twitter_over_2022.svg
  • bt_youtube_on_2022.svgbt_youtube_over_2022.svg
  • bt_instagram_on_2022.svgbt_instagram_over_2022.svg
The Korea Times
amn_close.png
amn_bl.png
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
amn_bl.png
Business
  • Tech
  • Bio
  • Companies
amn_bl.png
Finance
  • Companies
  • Economy
  • Markets
  • Cryptocurrency
amn_bl.png
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to President
  • Letter to the Editor
amn_bl.png
Lifestyle
  • Travel & Food
  • Trends
  • People & Events
  • Books
  • Around Town
  • Fortune Telling
amn_bl.png
Entertainment & Arts
  • K-pop
  • Films
  • Shows & Dramas
  • Music
  • Theater & Others
amn_bl.png
Sports
amn_bl.png
World
  • SCMP
  • Asia
amn_bl.png
Video
  • Korean Storytellers
  • POPKORN
  • Culture
  • People
  • News
amn_bl.png
Photos
  • Photo News
  • Darkroom
amn_NK.png amn_DR.png amn_LK.png amn_LE.png
  • bt_fb_on_2022.svgbt_fb_over_2022.svg
  • bt_twitter_on_2022.svgbt_twitter_over_2022.svg
  • bt_youtube_on_2022.svgbt_youtube_over_2022.svg
  • bt_instagram_on_2022.svgbt_instagram_over_2022.svg
  • Login
  • Register
  • Login
  • Register
  • The Korea Times
  • search
  • all menu
  • Login
  • Subscribe
  • Photos
  • Video
  • World
  • Sports
  • Opinion
  • Entertainment & Art
  • Lifestyle
  • Finance
  • Business
  • National
  • North Korea
  • 1

    INTERVIEWKorean adoptee in Germany reunites with birth family after 42 years

  • 3

    Revenge rises as key theme in K-dramas

  • 5

    World water day

  • 7

    Sexual assaults by Korean diplomats continue despite zero-tolerance policy

  • 9

    Jeon Jong-seo discusses her first Hollywood role in 'Mona Lisa and Blood Moon'

  • 11

    Samsung, SK avoid worst-case scenario as US 'guardrails' are less stringent than feared

  • 13

    Korea to start mass production of KF-21 in 2024

  • 15

    Korean pension fund hit by overseas banking crisis

  • 17

    Sandstorm from China forecast to push up fine dust levels in Korea

  • 19

    Daughter of North Korean dictator seen wearing $1,900 Dior jacket

  • 2

    Zebra captured after escaping from Seoul zoo

  • 4

    Consumers choose to travel abroad over purchasing luxury goods

  • 6

    Korean firms balk at donating to fund compensating victims of Japan's forced labor

  • 8

    Will exempting foreign nannies from minimum wage boost Korea's birth rate?

  • 10

    Outback Steakhouse sees sales soar as it opens stores in large shopping malls

  • 12

    Main opposition leader indicted, faces calls to resign

  • 14

    Yoo Yeon-seok threatens to sue people spreading accusations about him

  • 16

    Apple working on expanding Apple Pay service in Korea: senior executive

  • 18

    Childbirths sink 6% to fresh low in January

  • 20

    Campaign launched to promote equal treatment for multicultural families

Close scrollclosebutton

Close for 24 hours

Open
  • The Korea Times
  • search
  • all menu
  • Login
  • Subscribe
  • Photos
  • Video
  • World
  • Sports
  • Opinion
  • Entertainment & Art
  • Lifestyle
  • Finance
  • Business
  • National
  • North Korea
Business
Bio
  • Tech
  • Bio
  • Companies
Fri, March 24, 2023 | 15:34
Medytox takes patent fight with Hugel to USITC
Medytox takes patent fight with Hugel to USITC
Another patent war among domestic botulinum toxin (BTX or Botox) makers has broken out after Medytox accused its local competitor, Hugel, of stealing its BTX strains, filing a lawsuit with the United States International Trade Commission (USITC), according to company officials, Tuesday.
Baek Byung-yeul | 2022-04-05 16:47
Samsung Biologics eyes global market with acquisition of Samsung Bioepis: CEO
Samsung Biologics eyes global market with acquisition of Samsung Bioepis: CEO
Samsung Biologics, the biotech arm of Korea's Samsung Group, aims to expand its presence in the global market through full ownership of Samsung Bioepis, its chief executive said Tuesday.
2022-03-29 15:35
Regulator fines 3 Celltrion firms 13 bln won for violating accounting rules
Regulator fines 3 Celltrion firms 13 bln won for violating accounting rules
South Korea's financial regulator said Wednesday that it has fined three companies of pharmaceutical giant Celltrion a combined 13 billion won (US$10.5 million) for violating accounting rules.
2022-03-16 19:26
GL Rapha declines to halt Russian vaccine production in Korea
GL Rapha declines to halt Russian vaccine production in Korea
GL Rapha, one of the Korean manufacturers of Russia's Sputnik V and one-shot Sputnik Light coronavirus vaccines, has reaffirmed that it will continue producing and exporting the vaccines. The move contrasts with Huons Global, which decided recently to halt production of the Russian vaccines in Korea.
Park Jae-hyuk | 2022-03-11 14:12
Korea on right track, but long way to go to becoming vaccine hub
Korea on right track, but long way to go to becoming vaccine hub
Samsung Biologics, SK Bioscience and other biotech companies here are expanding their vaccine development and manufacturing capabilities, as the COVID-19 pandemic has highlighted the importance of having vaccine sovereignty, according to company officials Tuesday. Korea had a hard time securing COVID-19 vaccines when they were first available because the nation was at the mer...
Baek Byung-yeul | 2022-03-08 13:27
Ex-Beckman Coulter executive to lead Seegene's US office
Ex-Beckman Coulter executive to lead Seegene's US office
Richard S. Creager, a former chief science officer of U.S.-based medical diagnostics company Beckman Coulter, was appointed as CEO of Korean diagnostics company Seegene's U.S. subsidiary.
Baek Byung-yeul | 2022-03-03 14:25
Sputnik vaccine manufacturers in Korea wary of Russia sanctions
Sputnik vaccine manufacturers in Korea wary of Russia sanctions
Korea's contract development and manufacturing organizations (CDMOs) are facing concerns about a potential setback in their production of the Sputnik V and one-shot Sputnik Light vaccines against COVID-19, after the U.S. and the European Union began imposing tougher financial sanctions against Russia over its invasion of Ukraine.
Park Jae-hyuk | 2022-02-25 14:24
  • Escalating Ukraine crisis to weigh further on Korean exporters
Celltrion 2021 net soars 20% on robust overseas sales
Celltrion 2021 net soars 20% on robust overseas sales
Celltrion said Wednesday that its net profit jumped 20.1 percent year-on-year last year on the back of robust sales of its biosimilar products in overseas markets.
2022-02-16 14:59
HLB's US affiliate Verismo sets up Asia headquarters in Korea
HLB's US affiliate Verismo sets up Asia headquarters in Korea
Verismo Therapeutics, a new drug development company based in the U.S., established its Asia branch in Korea as part of its plan to facilitate clinical trials of its anti-cancer drug platform in the Asia region, the Korean biotech company HLB said Tuesday.
Baek Byung-yeul | 2022-02-15 17:16
Samsung Biologics to begin operations of 4th plant this year
Samsung Biologics to begin operations of 4th plant this year
Partial operations will begin in October of this year at Samsung Biologics' fourth plant currently being built in Songdo, west of Seoul. The move is part of efforts by the drug-manufacturing unit of Samsung Group to improve its capabilities in the contract manufacturing organization (CMO) business, its CEO said Thursday.
Baek Byung-yeul | 2022-01-13 16:24
123456 7 8
Top 10 Stories
1[INTERVIEW] Korean adoptee in Germany reunites with birth family after 42 years INTERVIEWKorean adoptee in Germany reunites with birth family after 42 years
2Will exempting foreign nannies from minimum wage boost Korea's birth rate? Will exempting foreign nannies from minimum wage boost Korea's birth rate?
3Korea to start mass production of KF-21 in 2024 Korea to start mass production of KF-21 in 2024
4Daughter of North Korean dictator seen wearing $1,900 Dior jacket Daughter of North Korean dictator seen wearing $1,900 Dior jacket
5Retailers rush to adopt Apple Pay system Retailers rush to adopt Apple Pay system
6Will Apple Pay launch boost local iPhone sales? Will Apple Pay launch boost local iPhone sales?
7[INTERVIEW] Expert pitches Laotian rural reform to solve NK's chronic food shortages INTERVIEWExpert pitches Laotian rural reform to solve NK's chronic food shortages
8[INTERVIEW] 'Welcome to world of art therapy' INTERVIEW'Welcome to world of art therapy'
9[INTERVIEW] Forbes-listed entrepreneur pursues partnerships with Samsung, LG, SK to help Ukraine INTERVIEWForbes-listed entrepreneur pursues partnerships with Samsung, LG, SK to help Ukraine
10Indonesian students advise Korean bank on entering Indonesian market Indonesian students advise Korean bank on entering Indonesian market
DARKROOM
  • Turkey-Syria earthquake

    Turkey-Syria earthquake

  • Nepal plane crash

    Nepal plane crash

  • Brazil capital uprising

    Brazil capital uprising

  • Happy New Year 2023

    Happy New Year 2023

  • World Cup 2022 Final - Argentina vs France

    World Cup 2022 Final - Argentina vs France

CEO & Publisher : Oh Young-jin
Digital News Email : webmaster@koreatimes.co.kr
Tel : 02-724-2114
Online newspaper registration No : 서울,아52844
Date of registration : 2020.02.05
Masthead : The Korea Times
Copyright © koreatimes.co.kr. All rights reserved.
  • About Us
  • Introduction
  • History
  • Contact Us
  • Products & Services
  • Subscribe
  • E-paper
  • RSS Service
  • Content Sales
  • Site Map
  • Policy
  • Code of Ethics
  • Ombudsman
  • Privacy Statement
  • Terms of Service
  • Copyright Policy
  • Family Site
  • Hankook Ilbo
  • Dongwha Group